Growth hormone deficiency and hypobetalipoproteinemia in a patient with Kabuki syndrome: a case report
Keywords:
Kabuki syndromeAbstract
Kabuki syndrome (KS) is a rare condition characterizeb by facial features (eversion of the lower lateral eyelid, arched eyebrows with the lateral one-third dispersed or sparsed, depressed nasal tip, and prominent ears), skeletal anomalies, dermatoglyphic abnormalities, short stature, and mental retardation. We describe a case of KS clinically diagnosed at 7 years of life on the basis of typical facial features, neurodevelopment delay, and growth failure; the diagnosi was gentically confirmed later in adolescence. Endocrinogy investigation performed for short stature revealed growth hormone deficiency (GHD). The treatment with rhGH from 8 years of life initially improved height velocity and stature, however the catch-up growth was only transient and final height was disappointing. The patient, investigated also for the presence of altered lipid profile, showed hypobetalipoproteinemia (HBL). At the best of our knowledge, this is the first case of KS with both GHD and HBL in literature. This case reinforces the awareness for the necessity to take in account that syndromes can combine with different unexpected genetic conditions in many cases.
References
Ito N, Ihara K, Tsutsumi Y, et al. Hypothalamic pituitary complications in Kabuki syndrome. Pituitary. 2013 Jun;16(2):133-8. doi: 10.1007/s11102-012-0386-8. PMID: 22434255.
Makrythanasis P, van Bon BW, Steehouwer M, et al. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study. Clin Genet. 2013 Dec;84(6):539-45. doi: 10.1111/cge.12081. Epub 2013 Apr 26. PMID: 23320472.
Adam MP, Banka S, Bjornsson HT, et al. Kabuki syndrome: international consensus diagnostic criteria. J Med Genet. 2019 Feb;56(2):89-95. doi: 10.1136/jmedgenet-2018-105625. Epub 2018 Dec 4. PMID: 30514738.
Schott DA, Gerver WJM, Stumpel CTRM. Growth Hormone Therapy in Children with Kabuki Syndrome: 1-year Treatment Results. Horm Res Paediatr. 2017;88(3-4):258-264. doi: 10.1159/000479368. Epub 2017 Aug 9. PMID: 28793284.
Schott DA, Stumpel CTRM, Klaassens M. Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment. Am J Med Genet A. 2019 Feb;179(2):219-223. doi: 10.1002/ajmg.a.60696. Epub 2018 Dec 17. PMID: 30556359; PMCID: PMC6590336.
Ruault V, Corsini C, Duflos C, et al. Growth charts in Kabuki syndrome 1. Am J Med Genet A. 2020 Mar;182(3):446-453. doi: 10.1002/ajmg.a.61462. Epub 2019 Dec 26. PMID: 31876365.
Shangguan H, Su C, Ouyang Q, et al. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature. Orphanet J Rare Dis. 2019 Nov 14;14(1):255. doi: 10.1186/s13023-019-1219-x. PMID: 31727177; PMCID: PMC6854618.
Van Laarhoven PM, Neitzel LR, Quintana AM, et al. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015 Aug 1;24(15):4443-53. doi: 10.1093/hmg/ddv180. Epub 2015 May 13. PMID: 25972376; PMCID: PMC4492403.
Roma D, Palma P, Capolino R, et al. Spinal ependymoma in a patient with Kabuki syndrome: a case report. BMC Med Genet. 2015 Sep 5;16:80. doi: 10.1186/s12881-015-0228-4. PMID: 26341229; PMCID: PMC4560867.
Wang YR, Xu NX, Wang J, Wang XM. Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms. World J Pediatr. 2019 Dec;15(6):528-535. doi: 10.1007/s12519-019-00309-4. Epub 2019 Oct 5. PMID: 31587141.
Van den Broeck J, Massa GG, Attanasio A, et al. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr. 1995 Nov;127(5):729-35. doi: 10.1016/s0022-3476(95)70161-3. PMID: 7472824.
Board KI: Kabi international growth hormone study (KIGS – Pfizer International Growth Database) http://medicaloutcomes.pfizer.com
Florakis D, Hung V, Kaltsas G, et al. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9. doi: 10.1046/j.1365-2265.2000.01108.x. PMID: 11012570.
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.